FridayDec 03, 2021 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Enters Cannabis Beverages Market, Extends Portfolio of Luxury Products with Tonino Lamborghini Licensing Agreement

Flora Growth recently entered into a licensing agreement to produce and distribute Tonino Lamborghini-branded cannabis beverages across North America and Colombia, with an initial focus on the U.S. market The company will produce the product line using molecular tagging and authentication technology that will guarantee product verification and allay concerns of counterfeit products Through the licensing agreement, Flora has entered into the cannabis beverages market amid increasing demand for CBD-based products The recent agreement follows a November 15 announcement that FLGC had completed the acquisition of Vessel Brand Inc., an industry leader in luxury cannabis consumer technology Internationally focused cannabis…

Continue Reading

ThursdayDec 02, 2021 9:00 am

Marijuana Company of America Inc. (MCOA) Leverages Strategic Partnerships to Facilitate Growth Within the Industry

The global cannabis market was valued at $22.10 billion and is expected to grow at a CAGR of 13.9% by 2026. The growing trend was reflected by Green Wednesday sales MCOA has expanded its interests into Latin America and has strategic partnerships in place, as well as wholly-owned subsidiaries in its portfolio Leadership team has set high standards for the company and plans to leverage the strategic partnerships it has accumulated as a means of facilitating growth for the company within the industry The cannabis industry just celebrated its second-largest holiday of the year – Green Wednesday, the industry’s very…

Continue Reading

WednesdayDec 01, 2021 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Expands its Line of Lifestyle Brands Following Vessel’s Merger into a Wholly-Owned Subsidiary

Flora Growth has followed through with its definitive agreement to acquire 100% of Vessel’s equity interests This acquisition opens Flora up to the North American market, in addition to expanding its brand portfolio, with a proven operator that has achieved trailing 12-months revenue of $6.6 million and year-over-year growth of 90% It also serves to strengthen Flora’s management with the addition of Vessel’s leadership onto the team This latest acquisition lines up with Flora’s mission to build a connected, design-led collective of plant-based wellness and lifestyle brands that offer customers an unrivaled experience Flora Growth (NASDAQ: FLGC) has, since its…

Continue Reading

TuesdayNov 30, 2021 9:30 am

Marijuana Company of America Inc. (MCOA) Reports Highest Quarterly Revenue Yet in Q3 2021 on the Back of New Acquisition, Expects Another Record-Breaking Quarter in Q4 2021

MCOA’s Q3 2021 revenue increased 731% year on year from $53,195 in Q3 2020 to $442,178 in Q3 2021 The company attributed this growth to its recent acquisition of cDistro, one of the fastest-growing distributors in North America cDistro’s acquisition is part of a strategic shift as the company looks to expand into new areas within the cannabis industry MCOA expects another record-breaking quarter in Q4 2021 as it anticipates reporting a full quarter of revenue from VBF Brands Inc., its newly acquired cultivation facility in Salinas, California Marijuana Company of America (OTC: MCOA), a diversified holding company looking to…

Continue Reading

MondayNov 29, 2021 9:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Schedules November 29th for Q3 2021 Financials Release; November 30th for Earnings Discussion

RWB is set to release its Q3 financial results on November 29, 2021 A conference call will follow this release on November 30, 2021, at 5:00 PM ET to discuss these results, the company’s operations, upcoming events, and a Q&A session A replay of the call will be available for 90 days, starting three hours after the conclusion RWB is increasingly optimistic about its Q3 performance following growth in revenue from Q1 to Q2, along with strategic investments that would allow for Q3 growth Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF) just announced that it will be releasing…

Continue Reading

MondayNov 29, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2022 Financial Results, Business Update Showing Positive Momentum Across All Its Programs

InMed Pharmaceuticals released Q1 2022 financial results in which it reported a year-on-year increase in research and development expenses primarily due to increased activities related to INM-755 clinical trials The company’s cash, cash equivalents, and short-term investments also grew quarter over quarter from $7.4 million to $15.4 million Following the closing of BayMedica’s acquisition, the integrated teams are working together with a focus on launching selected rare cannabinoids, growing revenue, and expanding sales InMed has commenced Phase 2 clinical trial of INM-755 (cannabinol) cream for the treatment of a group of rare skin disorders Preclinical data of INM-088, the company’s…

Continue Reading

WednesdayNov 24, 2021 8:00 am

Marijuana Company of America Inc. (MCOA) Set to Launch VapeTV U.S. in a Three-Way Partnership

MCOA just signed an LOI with VapeTV UK and Jasleen Enterprises for the launch of VapeTV U.S. This new company is set to offer in-store advertising within retail vape stores It will capitalize on the growing CBD industry and the ever-increasing demand for in-store media advertising in the United States Marijuana Company of America (OTC: MCOA) has announced the signing of a non-binding letter of intent (“LOI”) that marks the beginning of the process to form a new in-store advertising brand named VapeTV US, Inc. (https://cnw.fm/jfcGM).  VapeTV US will be the product of a three-way partnership among cDistro, Inc, a…

Continue Reading

TuesdayNov 23, 2021 8:30 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Adding to its Growing Retail Presence with Rapid Developments in Florida

Red White & Bloom Brands is building a multi-state operation in the cannabis and hemp industries through state subsidiaries focused on markets in Florida, Michigan, Illinois, Arizona and California The company is now rapidly building up its cultivation and retail operations in Florida, advancing from regulatory approval in the state last month to the startup of growing activity to supply existing and soon-to-open dispensaries in four cities from Miami to Daytona Beach and across to Spring Hill Florida is on the verge of a “massive medical marijuana boom” as the pain-conscious retirement community grows and residents’ attitudes overwhelmingly favor openness…

Continue Reading

ThursdayNov 18, 2021 8:00 am

Hero Technologies Inc. (HENC) Subsidiary Looks to Leverage Position in $2B Massachusetts Marijuana Market

HENC subsidiary evaluating, pursuing property acquisitions; beginning process to obtain cultivation, sales licenses Sales have doubled in the past year, according to state’s seed-to-sale tracking system HENC working with top cannabis law firm to spearhead the process With Massachusetts reporting marijuana sales reaching $2 billion since the state approved the adult-use market (https://cnw.fm/9CA5M), savvy cannabis companies operating in the state are looking to leverage opportunity for growth. Earlier this year, Hero Technologies (OTC: HENC), a cannabis company pursuing a vertically integrated model, announced a new subsidiary: MassCannabis LLC. The newly formed company is evaluating and pursuing property acquisitions and beginning the process…

Continue Reading

ThursdayNov 18, 2021 8:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces 2022 DehydraTECH(TM) R&D Programs, Including Investigations into Alzheimer’s Disease and Diabetes

Lexaria’s 2022 R&D programs are set to include research on hormone replacement, dementia, rheumatoid disease, and diabetes, among other conditions The program builds on findings from 2021 studies which supported significant advances in the oral nicotine, heart disease, and antiviral markets The 2022 program will continue to focus on the company’s patented DehydraTECH drug delivery platform Lexaria will also be conducting pharmacokinetic and efficacy modeling studies in animals to evaluate DehydraTECH’s overall efficiency In 2021, Lexaria Bioscience (NASDAQ: LEXX) raised approximately $15 million in funding. The money allowed for active work programs throughout the year while supporting significant advances in…

Continue Reading

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 303.498.7722